Literature DB >> 26486418

Diabetes and diabetic retinopathy in people aged 50 years and older in the Republic of Suriname.

Janna Minderhoud1, Jerrel C Pawiroredjo2, Anne-Marie T Bueno de Mesquita-Voigt2, Herman Ci Themen2, Michael R Siban2, Cindy M Forster-Pawiroredjo2, Hans Limburg3, Ruth Ma van Nispen4, Dennis Ra Mans5, Annette C Moll4.   

Abstract

BACKGROUND/AIMS: Population-based surveys on diabetes and diabetic retinopathy (DR) are necessary to increase awareness and develop screening and therapeutic programmes. The aim was to estimate the prevalence of DR in older adults of different ethnic backgrounds in Suriname.
METHODS: Fifty clusters of 60 people aged ≥50 years were randomly selected with a probability proportional to the size of the population unit. Eligible people were randomly selected through compact segment sampling and examined using the Rapid Assessment of Avoidable Blindness plus Diabetic Retinopathy (RAAB + DR) protocol. Participants were classified as having diabetes if they: were previously diagnosed with diabetes; were receiving treatment for glucose control; had a random blood glucose level >200 mg/dL. These participants were dilated for funduscopy, assessed for DR following the Scottish DR grading protocol and evaluated for ethnicity and DR ophthalmic screening frequencies.
RESULTS: A total of 2806 individuals was examined (response 93.6%). The prevalence of diabetes was 24.6%. In these patients any type of DR and/or maculopathy occurred in 21.6% and sight-threatening DR in 8.0%. Of the known diabetics, 34.2% never had an eye examination for DR and in 13.0% the last examination was >24 months ago. The prevalence of diabetes was significantly higher in Hindustani people compared with other major ethnic groups.
CONCLUSIONS: The prevalence of diabetes and diabetics without regular DR control in people aged ≥50 years in Suriname was higher than expected. The uptake for special services for DR has to be expanded to decrease patient delay and DR-induced blindness. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Epidemiology; Public health; Retina

Mesh:

Substances:

Year:  2015        PMID: 26486418     DOI: 10.1136/bjophthalmol-2015-307177

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Relationship between diabetes mellitus and cataract in Hungary.

Authors:  Anita Pék; Dorottya Szabó; Gábor László Sándor; Gábor Tóth; András Papp; Zoltán Zsolt Nagy; Hans Limburg; János Németh
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  Comparison of cardiovascular risk factors and dietary intakes among Javanese Surinamese and South-Asian Surinamese in the Netherlands. The HELIUS study.

Authors:  Qaisar Raza; Marieke B Snijder; Jacob C Seidell; Ron J G Peters; Mary Nicolaou
Journal:  BMC Res Notes       Date:  2017-01-06

Review 3.  An updated systematic review and meta-analysis on the social determinants of diabetes and related risk factors in the Caribbean.

Authors:  Leonor Guariguata; Catherine Brown; Natasha Sobers; Ian Hambleton; T Alafia Samuels; Nigel Unwin
Journal:  Rev Panam Salud Publica       Date:  2018-12-17

Review 4.  Rapid Assessment of Avoidable Blindness: looking back, looking forward.

Authors:  Islay Mactaggart; Hans Limburg; Andrew Bastawrous; Matthew J Burton; Hannah Kuper
Journal:  Br J Ophthalmol       Date:  2019-07-02       Impact factor: 4.638

Review 5.  Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.

Authors:  M Larissa Avilés-Santa; Alberto Monroig-Rivera; Alvin Soto-Soto; Nangel M Lindberg
Journal:  Curr Diab Rep       Date:  2020-10-10       Impact factor: 4.810

6.  Diabetic care initiatives to prevent blindness from diabetic retinopathy in India.

Authors:  G V S Murthy; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.